These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2311653)

  • 21. Benefits of external qigong therapy on morphine-abstinent mice and rats.
    Mo Z; Chen KW; Ou W; Li M
    J Altern Complement Med; 2003 Dec; 9(6):827-35. PubMed ID: 14736354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adenosinergic system is involved in sensitization to morphine withdrawal signs in rats-neurochemical and molecular basis in dopaminergic system.
    Listos J; Baranowska-Bosiacka I; Wąsik A; Talarek S; Tarnowski M; Listos P; Łupina M; Antkiewicz-Michaluk L; Gutowska I; Tkacz M; Pilutin A; Orzelska-Górka J; Chlubek D; Fidecka S
    Psychopharmacology (Berl); 2016 Jun; 233(12):2383-97. PubMed ID: 27087433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat strain differences in the opiate abstinence syndrome.
    Gonzalez LP; Altshuler HL
    Behav Biol; 1978 Oct; 24(2):209-19. PubMed ID: 310675
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of alprazolam on opiate withdrawal: a combined behavioural and microdialysis study.
    Gray AM
    Eur J Pharmacol; 1996 Oct; 313(1-2):73-7. PubMed ID: 8905331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental "auricular electroacupuncture" in morphine-dependent rats: behavioral and biochemical observations.
    Ng LK; Thoa NG; Douthitt TC; Albert CA
    Am J Chin Med (Gard City N Y); 1975 Oct; 3(4):335-41. PubMed ID: 1239186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Butorphanol precipitates abstinence in morphine dependent rats.
    Horan P; Ho IK
    Eur J Pharmacol; 1989 Nov; 170(3):265-8. PubMed ID: 2620698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An assessment of the individual sensitivity of Wistar rats to the development of morphine dependence].
    Konstantinopol'skiĭ MA; Surkova LA; Tiurina IV; Sudakov SK
    Eksp Klin Farmakol; 1992; 55(2):9-11. PubMed ID: 1422464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Swimming reduces the severity of physical and psychological dependence and voluntary morphine consumption in morphine dependent rats.
    Fadaei A; Gorji HM; Hosseini SM
    Eur J Pharmacol; 2015 Jan; 747():88-95. PubMed ID: 25498794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral and neurochemical effects of electroconvulsive shock in the withdrawal syndrome of morphine dependent rats.
    Ng LK; Thoa NB; Ebert MH
    Acupunct Electrother Res; 1981; 6(1):33-46. PubMed ID: 6121466
    [No Abstract]   [Full Text] [Related]  

  • 33. Treadmill exercise attenuates the severity of physical dependence, anxiety, depressive-like behavior and voluntary morphine consumption in morphine withdrawn rats receiving methadone maintenance treatment.
    Alizadeh M; Zahedi-Khorasani M; Miladi-Gorji H
    Neurosci Lett; 2018 Aug; 681():73-77. PubMed ID: 29859324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of calcitonin on morphine tolerance and withdrawal syndrome in morphine physically dependent rats.
    Clementi G; Valerio C; Prato A; Caruso A; Patti F; Patanè S; Drago F
    Eur J Pharmacol; 1989 Apr; 163(1):175-9. PubMed ID: 2744091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physical dependence liabilities of oxybutynin and morphine in rats.
    Algate DR; Beard DJ
    Arzneimittelforschung; 1985; 35(10):1577-9. PubMed ID: 4074417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral changes produced in the cat by acute and chronic morphine injection and naloxone precipitated withdrawal.
    French ED; Vasquez SA; George R
    Eur J Pharmacol; 1979 Aug; 57(4):387-97. PubMed ID: 573695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats.
    Chang AP; Dixon WR
    J Pharmacol Exp Ther; 1990 Sep; 254(3):857-63. PubMed ID: 2395117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.